An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 9, 2014, Pages 2961-2969

  Gerstmeier, Jana ^a   Weinigel, Christina ^b   Barz, Dagmar ^b   Werz, Oliver ^a   Garscha, Ulrike ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

12 Lipoxygenase; 5 Lipoxygenase; 5 Lipoxygenase activating protein; Arachidonic acid; HEK293 cells; MK886

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CALCIMYCIN; LEUKOTRIENE; LEUKOTRIENE B4 DERIVATIVE;

ARTICLE; CELL NUCLEUS MEMBRANE; CELLULAR SECRETION; CONCENTRATION (PARAMETERS); CYTOLOGY; ENZYME LOCALIZATION; FATTY ACID SYNTHESIS; GENETIC TRANSFECTION; HEK293 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKOTRIENE BIOSYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

12-LIPOXYGENASE; 5-LIPOXYGENASE; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONIC ACID; HEK293 CELLS; MK886;

5-LIPOXYGENASE-ACTIVATING PROTEINS; ARACHIDONATE 5-LIPOXYGENASE; CALCIMYCIN; CALCIUM IONOPHORES; CELL NUCLEUS; HEK293 CELLS; HUMANS; INDOLES; LEUKOTRIENES; LIPOXYGENASE INHIBITORS;

EID: 84903726819     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.05.016     Document Type: Article

References (42)

1. M. Peters-Golden, and W.R. Henderson Jr. Leukotrienes N. Engl. J. Med. 357 2007 1841 1854
2. R.L. Maas, C.D. Ingram, D.F. Taber, J.A. Oates, and A.R. Brash Stereospecific removal of the DR hydrogen atom at the 10-carbon of arachidonic acid in the biosynthesis of leukotriene A4 by human leukocytes J. Biol. Chem. 257 1982 13515 13519 (Pubitemid 13187112)
3. A. Panossian, M. Hamberg, and B. Samuelsson On the mechanism of biosynthesis of leukotrienes and related compounds FEBS Lett. 150 1982 511 513 (Pubitemid 13184099)
4. C.N. Serhan, M. Hamberg, and B. Samuelsson Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes Proc. Natl. Acad. Sci. U. S. A. 81 1984 5335 5339 (Pubitemid 14048742)
5. M. Minami, S. Ohno, H. Kawasaki, O. Radmark, B. Samuelsson, H. Jornvall, T. Shimizu, Y. Seyama, and K. Suzuki Molecular cloning of a cDNA coding for human leukotriene A4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesis J. Biol. Chem. 262 1987 13873 13876 (Pubitemid 17152083)
6. J.F. Penrose LTC4 synthase. Enzymology, biochemistry, and molecular characterization Clin. Rev. Allergy Immunol. 17 1999 133 152
7. M. Rakonjac, L. Fischer, P. Provost, O. Werz, D. Steinhilber, B. Samuelsson, and O. Radmark Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production Proc. Natl. Acad. Sci. U. S. A. 103 2006 13150 13155 (Pubitemid 44338931)
8. O. Werz, E. Burkert, L. Fischer, D. Szellas, D. Dishart, B. Samuelsson, O. Radmark, and D. Steinhilber 5-Lipoxygenase activation by MAPKAPK-2 and ERKs Adv. Exp. Med. Biol. 525 2003 129 132 (Pubitemid 36667718)
9. R.A. Dixon, R.E. Diehl, E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard, and D.K. Miller Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis Nature 343 1990 282 284
10. C.A. Rouzer, A.W. Ford-Hutchinson, H.E. Morton, and J.W. Gillard MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes J. Biol. Chem. 265 1990 1436 1442
11. J.W. Woods, J.F. Evans, D. Ethier, S. Scott, P.J. Vickers, L. Hearn, J.A. Heibein, S. Charleson, and I.I. Singer 5-Lipoxygenase and 5-lipoxygenase- activating protein are localized in the nuclear envelope of activated human leukocytes J. Exp. Med. 178 1993 1935 1946 (Pubitemid 23344852)
12. P.J. Jakobsson, R. Morgenstern, J. Mancini, A. Ford-Hutchinson, and B. Persson Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily Am. J. Respir. Crit. Care Med. 161 2000 S20 S24
13. S. Charleson, P. Prasit, S. Leger, J.W. Gillard, P.J. Vickers, J.A. Mancini, P. Charleson, J. Guay, A.W. Ford-Hutchinson, and J.F. Evans Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition Mol. Pharmacol. 41 1992 873 879 (Pubitemid 23023330)
14. S. Kargman, P.J. Vickers, and J.F. Evans A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells J. Cell Biol. 119 1992 1701 1709
15. X.S. Chen, Y.Y. Zhang, and C.D. Funk Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein/5-lipoxygenase fusion proteins J. Biol. Chem. 273 1998 31237 31244 (Pubitemid 28533139)
16. O. Werz, E. Burkert, B. Samuelsson, O. Radmark, and D. Steinhilber Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes Blood 99 2002 1044 1052 (Pubitemid 34527142)
17. C. Pergola, A. Rogge, G. Dodt, H. Northoff, C. Weinigel, D. Barz, O. Radmark, L. Sautebin, and O. Werz Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes FASEB J. 25 2011 3377 3387
18. O. Werz, D. Szellas, D. Steinhilber, and O. Radmark Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2) J. Biol. Chem. 277 2002 14793 14800 (Pubitemid 34959961)
19. C. Pergola, G. Dodt, A. Rossi, E. Neunhoeffer, B. Lawrenz, H. Northoff, B. Samuelsson, O. Radmark, L. Sautebin, and O. Werz ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma Proc. Natl. Acad. Sci. U. S. A. 105 2008 19881 19886
20. P. Borgeat, and B. Samuelsson Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187 Proc. Natl. Acad. Sci. U. S. A. 76 1979 2148 2152 (Pubitemid 9184898)
21. + and differentially interact with platelet-type 12-lipoxygenase Mol. Pharmacol. 70 2006 1071 1078 (Pubitemid 44268464)
22. J. Gillard, A.W. Ford-Hutchinson, C. Chan, S. Charleson, D. Denis, A. Foster, R. Fortin, S. Leger, C.S. McFarlane, and H. Morton et al. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor Can. J. Physiol. Pharmacol. 67 1989 456 464 (Pubitemid 19186702)
23. S. Charleson, J.F. Evans, S. Leger, H. Perrier, P. Prasit, Z. Wang, and P.J. Vickers Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein Eur. J. Pharmacol. 267 1994 275 280
24. G.W. Carter, P.R. Young, D.H. Albert, J. Bouska, R. Dyer, R.L. Bell, J.B. Summers, and D.W. Brooks 5-lipoxygenase inhibitory activity of zileuton J. Pharmacol. Exp. Ther. 256 1991 929 937
25. O. Radmark, O. Werz, D. Steinhilber, and B. Samuelsson 5-Lipoxygenase: regulation of expression and enzyme activity Trends Biochem. Sci. 32 2007 332 341 (Pubitemid 47021417)
26. M.E. Surette, R. Palmantier, J. Gosselin, and P. Borgeat Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen J. Exp. Med. 178 1993 1347 1355 (Pubitemid 23277366)
27. J.F. Evans, A.D. Ferguson, R.T. Mosley, and J.H. Hutchinson What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases Trends Pharmacol. Sci. 29 2008 72 78
28. N.S. Stock, G. Bain, J. Zunic, Y. Li, J. Ziff, J. Roppe, A. Santini, J. Darlington, P. Prodanovich, C.D. King, C. Baccei, C. Lee, H. Rong, C. Chapman, A. Broadhead, D. Lorrain, L. Correa, J.H. Hutchinson, J.F. Evans, and P. Prasit 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2- y lmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor J. Med. Chem. 54 2011 8013 8029
29. A.K. Mandal, J. Skoch, B.J. Bacskai, B.T. Hyman, P. Christmas, D. Miller, T.T. Yamin, S. Xu, D. Wisniewski, J.F. Evans, and R.J. Soberman The membrane organization of leukotriene synthesis Proc. Natl. Acad. Sci. U. S. A. 101 2004 6587 6592 (Pubitemid 38586018)
30. A.K. Mandal, P.B. Jones, A.M. Bair, P. Christmas, D. Miller, T.T. Yamin, D. Wisniewski, J. Menke, J.F. Evans, B.T. Hyman, B. Bacskai, M. Chen, D.M. Lee, B. Nikolic, and R.J. Soberman The nuclear membrane organization of leukotriene synthesis Proc. Natl. Acad. Sci. U. S. A. 105 2008 20434 20439
31. M. Abramovitz, E. Wong, M.E. Cox, C.D. Richardson, C. Li, and P.J. Vickers 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase Eur. J. Biochem. 215 1993 105 111 (Pubitemid 23211131)
32. J.A. Mancini, M. Abramovitz, M.E. Cox, E. Wong, S. Charleson, H. Perrier, Z. Wang, P. Prasit, and P.J. Vickers 5-Lipoxygenase-activating protein is an arachidonate binding protein FEBS Lett. 318 1993 277 281 (Pubitemid 23071752)
33. A.M. Bair, M.V. Turman, C.A. Vaine, R.A. Panettieri Jr., and R.J. Soberman The nuclear membrane leukotriene synthetic complex is a signal integrator and transducer Mol. Biol. Cell 23 2012 4456 4464
34. N.C. Gilbert, S.G. Bartlett, M.T. Waight, D.B. Neau, W.E. Boeglin, A.R. Brash, and M.E. Newcomer The structure of human 5-lipoxygenase Science 331 2011 217 219
35. A.D. Ferguson, B.M. McKeever, S. Xu, D. Wisniewski, D.K. Miller, T.T. Yamin, R.H. Spencer, L. Chu, F. Ujjainwalla, B.R. Cunningham, J.F. Evans, and J.W. Becker Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein Science 317 2007 510 512 (Pubitemid 47196114)
36. +- sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 12 1997 715 725 (Pubitemid 27200322)
37. C. Pergola, J. Gerstmeier, B. Monch, B. Caliskan, S. Luderer, C. Weinigel, D. Barz, J. Maczewsky, S. Pace, A. Rossi, L. Sautebin, E. Banoglu, and O. Werz The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP) Br. J. Pharmacol. 171 12 2014 3051 3064
38. D. Steinhilber, S. Hoshiko, J. Grunewald, O. Radmark, and B. Samuelsson Serum factors regulate 5-lipoxygenase activity in maturating HL60 cells Biochim. Biophys. Acta 1178 1993 1 8 (Pubitemid 23236091)
39. L. Fischer, M. Hornig, C. Pergola, N. Meindl, L. Franke, Y. Tanrikulu, G. Dodt, G. Schneider, D. Steinhilber, and O. Werz The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products Br. J. Pharmacol. 152 2007 471 480 (Pubitemid 47585043)
40. C.A. Rouzer, E. Rands, S. Kargman, R.E. Jones, R.B. Register, and R.A. Dixon Characterization of cloned human leukocyte 5-lipoxygenase expressed in mammalian cells J. Biol. Chem. 263 1988 10135 10140
41. M.E. Newcomer, and N.C. Gilbert Location, location, location: compartmentalization of early events in leukotriene biosynthesis J. Biol. Chem. 285 2010 25109 25114
42. D. Singh, M. Boyce, V. Norris, S.E. Kent, and J.H. Bentley Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study Int. J. Gen. Med. 6 2013 897 903